Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates
Journal of Infection, Volume 52, No. 3, Year 2006
Notification
URL copied to clipboard!
Description
Objective: The aim of this cross-sectional study was to evaluate the prevalence of hepatitis B 'e' antigen (HBeAg) and hepatitis B surface antigen (HBsAg) in pregnant women in the Gulf States. Methods: A total of 1710 pregnant women aged 15-45 years were enrolled in June-July 2000 in nine centres across Oman, Qatar and Unite Arab Emirates. The percentage of HBsAg-positive and HBeAg-positive individuals was determined. Results: Serology results were available for 1694 women. A total of 7.1% of the women in Oman, 1% in Qatar and 1.5% in UAE were HBsAg-positive. Three (0.5%) women in Oman were HBeAg-positive. Risk factors identified for being HBsAg-positive were younger age, being a national (i.e. not an expatriate) and residing outside the city. Conclusions: Results from this study have shown that hepatitis B virus (HBV) prevalence in pregnant women is of intermediate endemicity in Oman and of low endemicity in Qatar and UAE. Thus, universal vaccination of all female adolescents before potential pregnancy is recommended in Oman in order to prevent perinatal infection, as well as to minimize horizontal transmission of the HBV in the community. © 2005 the British Infection Society. Published by Elsevier Ltd. All rights reserved.
Authors & Co-Authors
Al-Awaidy, Salah Thabit
Oman, Muscat
Ministry of Health Oman
Abu-Elyazeed, Remon R.
Belgium, Rixensart
Glaxosmithkline Biologicals S.a.
Al Hosani, Hajer
United Arab Emirates, Dubai
Ministry of Health and Prevention
Al Mulla, Ahmed
Qatar, Doha
Hamad Medical Corporation
Al Busaiedy, Sulieman
Oman, Muscat
Ministry of Health Oman
Al Amiry, Amin
United Arab Emirates, Dubai
Ministry of Health and Prevention
Farah, Zeinab
United Arab Emirates, Dubai
Ministry of Health and Prevention
Al Marrie, Ajayeb
Qatar, Doha
Hamad Medical Corporation
Bock, Hans Ludwig
Belgium, Rixensart
Glaxosmithkline Biologicals S.a.
Al-Shaar, Ibrahim
Qatar, Health
Ministry of Public
Shah, Syed
Qatar, Health
Ministry of Public
Statistics
Citations: 54
Authors: 11
Affiliations: 5
Identifiers
Doi:
10.1016/j.jinf.2005.05.006
ISSN:
01634453
Research Areas
Infectious Diseases
Maternal And Child Health
Sexual And Reproductive Health
Study Design
Cross Sectional Study
Study Approach
Quantitative
Participants Gender
Female